Clinical Trials Directory

Trials / Unknown

UnknownNCT06313255

A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this retrospective observational study is to find out the effects of probiotics on HBV clearance. The main question it aims to answer is: Are the probiotics have an effect in promoting HBV clearance? The participants will observe the HBV clearance rate in chronic hepatitis B patients receive probiotics in addition to the routine antiviral therapy. Researchers will compare the HBV clearance rate in chronic hepatitis B patients receive probiotics and antiviral therapy with those receiving solely antiviral therapy.

Conditions

Interventions

TypeNameDescription
DRUGPegIFNα2bThe patients receive PegIFNα2b therapy
DRUGPegIFNα2b+probioticsThe patients receive both PegIFNα2b and probiotics therapy
DRUGNucleoside analogThe patients receive nucleoside analog therapy
DRUGNucleoside analog+probioticsThe patients receive both nucleoside analog and probiotics therapy

Timeline

Start date
2023-05-09
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2024-03-15
Last updated
2024-05-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06313255. Inclusion in this directory is not an endorsement.